Skip to main content
OpenTrials
Completed

NCT Number: NCT02445313

Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participants will allow us to demonstrate the advancement of different technologies, as well be used to allow comparisons between current technologies.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age-related Macular Degeneration (AMD) Eye Diseases Macular Degeneration Retinal Degeneration Retinal Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Doheny Eye Centers UCLA

Pasadena, California, 91105, United States

About this study

To test the quality of images from the Nidek MP-3 device and to measure Geographic Atrophy (GA) in patients with Age-related Macular Degeneration (AMD).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Normal, healthy participants and patients with AMD

Exclusion criteria

  • Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging
  • Participants who are unable to maintain retinal fixation on a specified target
  • Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place
  • Patients with media opacity which preclude high quality imaging will be excluded.
  • Exclusion criteria include vulnerable patients; patients under 18, pregnant, economically and educationally disadvantaged, decision impaired, or homeless people. We exclude pregnant women because pregnancy often can alter eye anatomy.

Treatment and study plan

Nidek MP-3

Device

Nidek MP-3 device to be used to take images which will allow measurement of GA in patients with AMD

Primary outcomes

  1. Geographic Atrophy

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Doheny Image Reading Center

Other

Registry information

Important dates

Study start
2015
Primary completion
2019
Study completion
2019
First posted
May 15, 2015
Registry last updated
Feb 15, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.